AVITA Medical, Inc. (RCEL) Non Operating Interest Expenses (2018 - 2026)

AVITA Medical (RCEL) has reported Non Operating Interest Expenses for 9 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses rose 16.85% year-over-year to $1.5 million; the trailing twelve-month figure through Jun 2026 stood at $5.2 million (up 1.77% YoY), and the FY2025 full-year result was $5.0 million, down 6.66% from the prior year.
• Non Operating Interest Expenses rose to $1.5 million in Q2 2026 per RCEL's latest filing, from $1.2 million in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $1.5 million in Q2 2026 and bottomed at $4000.0 in Q1 2023.
• Historically, Non Operating Interest Expenses has averaged $865400.0 across 5 years, with a median of $1.2 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Non Operating Interest Expenses sank 71.43% in 2022, then soared 33800.0% in 2024.
• Over 5 years, Non Operating Interest Expenses stood at $6000.0 in 2022, then soared by 18600.0% to $1.1 million in 2023, then increased by 15.69% to $1.3 million in 2024, then dropped by 3.7% to $1.2 million in 2025, then climbed by 17.04% to $1.5 million in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $1.5 million, $1.2 million, and $1.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.